Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$52.83 - $78.22 $44,324 - $65,626
-839 Reduced 2.53%
32,339 $2.5 Million
Q2 2023

Aug 14, 2023

BUY
$73.76 - $85.98 $2.45 Million - $2.85 Million
33,178 New
33,178 $2.71 Million
Q2 2020

Aug 14, 2020

SELL
$185.43 - $279.56 $4.7 Million - $7.09 Million
-25,356 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$161.17 - $221.51 $442,733 - $608,487
-2,747 Reduced 9.77%
25,356 $4.81 Million
Q4 2019

Feb 14, 2020

SELL
$189.68 - $222.09 $23,330 - $27,317
-123 Reduced 0.44%
28,103 $6.17 Million
Q3 2019

Nov 14, 2019

SELL
$183.56 - $216.72 $48,643 - $57,430
-265 Reduced 0.93%
28,226 $5.52 Million
Q2 2019

Aug 14, 2019

BUY
$188.72 - $215.43 $316,106 - $360,845
1,675 Added 6.25%
28,491 $5.94 Million
Q1 2019

May 15, 2019

BUY
$136.09 - $200.44 $240,607 - $354,377
1,768 Added 7.06%
26,816 $5.32 Million
Q4 2018

Feb 14, 2019

SELL
$132.75 - $203.8 $22,302 - $34,238
-168 Reduced 0.67%
25,048 $3.63 Million
Q3 2018

Nov 14, 2018

SELL
$147.44 - $204.11 $2.34 Million - $3.24 Million
-15,873 Reduced 38.63%
25,216 $5.15 Million
Q2 2018

Aug 14, 2018

BUY
$144.9 - $165.58 $352,686 - $403,021
2,434 Added 6.3%
41,089 $6.08 Million
Q1 2018

May 15, 2018

BUY
$131.46 - $151.04 $76,772 - $88,207
584 Added 1.53%
38,655 $5.84 Million
Q4 2017

Feb 14, 2018

SELL
$121.17 - $134.75 $70,642 - $78,559
-583 Reduced 1.51%
38,071 $4.93 Million
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $52,251 - $56,938
460 Added 1.2%
38,654 $4.67 Million
Q2 2017

Aug 14, 2017

BUY
N/A
38,194
38,194 $4.49 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track First Light Asset Management, LLC Portfolio

Follow First Light Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.